Business Context and Reporting Period
This Form 8-K is filed by Intellisense Solutions Inc. (Nevada), reporting an event dated September 16, 2019, with the report date of November 1, 2019. The filing addresses a Securities Exchange Agreement previously entered into with Medigus Ltd., under which Medigus's subsidiary, ScoutCam Ltd., was to become a wholly-owned subsidiary of Intellisense in exchange for 60% of Intellisense's issued and outstanding share capital.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, or existing debt levels. The primary financial data point disclosed relates to the funding condition required to close the transaction with Medigus:
- Investment Requirement: The agreement required the company to secure at least $3 million in investment funds.
- Valuation Basis: The investment was based on a pre-money valuation of $10 million.
- Funds Secured: As of October 31, 2019, the company secured commitments for $3.5 million.
Material Changes
The material change reported is the satisfaction of a key closing condition for the acquisition of ScoutCam Ltd. On October 31, 2019, Intellisense Solutions Inc. notified Medigus that it had secured $3.5 million in investment commitments, exceeding the $3 million threshold stipulated in the Securities Exchange Agreement.
Guidance, Outlook, and Risks
The filing contains a cautionary note regarding forward-looking statements. Management notes that statements concerning the timing and closing of the Agreement are based on current estimates and assumptions. The company explicitly states that actual results may differ significantly due to known and unknown risks and uncertainties. The company undertakes no obligation to update these forward-looking statements.
Investor Verification Checklist
- Verify the full text of the Securities Exchange Agreement filed as Exhibit 10.1 to the Initial 8-K (filed September 17, 2019) to understand all closing conditions beyond the funding requirement.
- Confirm the final closing date of the transaction and the issuance of shares to Medigus following the funding commitment.
- Review subsequent filings to determine if the $3.5 million in commitments was fully converted to cash and if the acquisition of ScoutCam Ltd. was completed.
- Assess the impact of the 60% equity dilution on existing shareholders once the transaction closes.